Pages that link to "Q57423301"
Jump to navigation
Jump to search
The following pages link to Zinc-alpha2-glycoprotein Expression as a Predictor of Metastatic Prostate Cancer Following Radical Prostatectomy (Q57423301):
Displaying 44 items.
- Crystal structure of the novel complex formed between zinc alpha2-glycoprotein (ZAG) and prolactin-inducible protein (PIP) from human seminal plasma (Q24324763) (← links)
- Cigarette smoking induces overexpression of a fat-depleting gene AZGP1 in the human (Q24648354) (← links)
- Integration of Breast Cancer Secretomes with Clinical Data Elucidates Potential Serum Markers for Disease Detection, Diagnosis, and Prognosis (Q31111254) (← links)
- Detection of aggressive prostate cancer associated glycoproteins in urine using glycoproteomics and mass spectrometry. (Q33609420) (← links)
- Quantitative proteomic profiling of prostate cancer reveals a role for miR-128 in prostate cancer (Q33697764) (← links)
- Identification of serum proteins involved in pancreatic cancer cachexia (Q33752632) (← links)
- Cyclin D1 splice variants: polymorphism, risk, and isoform-specific regulation in prostate cancer (Q33768593) (← links)
- The role of GATA2 in lethal prostate cancer aggressiveness (Q33848134) (← links)
- Proteomic analysis of urinary upper gastrointestinal cancer markers (Q33888474) (← links)
- Integrative Analysis of N-Linked Human Glycoproteomic Data Sets Reveals PTPRF Ectodomain as a Novel Plasma Biomarker Candidate for Prostate Cancer (Q34228757) (← links)
- The search for secreted proteins in prostate cancer by the Escherichia coli ampicillin secretion trap: expression of NBL1 is highly restricted to the prostate and is related to cancer progression (Q34403242) (← links)
- PTEN genomic deletion predicts prostate cancer recurrence and is associated with low AR expression and transcriptional activity (Q34484407) (← links)
- A three-protein biomarker panel assessed in diagnostic tissue predicts death from prostate cancer for men with localized disease (Q34998516) (← links)
- Zinc-α-2-glycoprotein: a candidate biomarker for colon cancer diagnosis in Chinese population (Q35016495) (← links)
- Proteomics profiling identify CAPS as a potential predictive marker of tamoxifen resistance in estrogen receptor positive breast cancer (Q35313220) (← links)
- The Role of the Basal Stem Cell of the Human Breast in Normal Development and Cancer (Q35669146) (← links)
- Cancer Chemoprevention with Korean Angelica: Active Compounds, Pharmacokinetics, and Human Translational Considerations. (Q36326652) (← links)
- Decreased expression of zinc-alpha2-glycoprotein in hepatocellular carcinoma associates with poor prognosis (Q36334864) (← links)
- Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer. (Q36678643) (← links)
- Chemopreventive effect of Korean Angelica root extract on TRAMP carcinogenesis and integrative "omic" profiling of affected neuroendocrine carcinomas (Q36915415) (← links)
- Anti-major histocompatibility complex class I-related chain A antibodies in organ transplantation (Q37218092) (← links)
- Markers for detection of prostate cancer. (Q37328403) (← links)
- Using molecular markers to help predict who will fail after radical prostatectomy (Q37957896) (← links)
- The role of treatment modality on the utility of predictive tissue biomarkers in clinical prostate cancer: a systematic review (Q38063121) (← links)
- Proteins from formalin-fixed paraffin-embedded prostate cancer sections that predict the risk of metastatic disease. (Q38384375) (← links)
- Zinc α2-glycoprotein as a potential novel urine biomarker for the early diagnosis of prostate cancer (Q39545306) (← links)
- Reduced AZGP1 expression is an independent predictor of early PSA recurrence and associated with ERG-fusion positive and PTEN deleted prostate cancers (Q40526157) (← links)
- Chemokine markers predict biochemical recurrence of prostate cancer following prostatectomy (Q42660306) (← links)
- Loss of Expression of AZGP1 Is Associated With Worse Clinical Outcomes in a Multi-Institutional Radical Prostatectomy Cohort (Q42845103) (← links)
- A role for GATA-2 in transition to an aggressive phenotype in prostate cancer through modulation of key androgen-regulated genes. (Q43291102) (← links)
- Evaluation of Serum Zinc Level Under Malignant Condition and its Possible Implication on Improving Cell-Mediated Immunity During Cancer Progression (Q45874570) (← links)
- rs4215 SNP in zinc-α2-glycoprotein gene is associated with obesity in Chinese north Han population (Q48010250) (← links)
- AZGP1 inhibits soft tissue sarcoma cells invasion and migration (Q48192538) (← links)
- A prospective multicentre phase III validation study of AZGP1 as a biomarker in localized prostate cancer. (Q50660769) (← links)
- Downregulation of AZGP1 by Ikaros and histone deacetylase promotes tumor progression through the PTEN/Akt and CD44s pathways in hepatocellular carcinoma (Q51250068) (← links)
- Loss of AZGP1 as a Superior Predictor of Relapse in Margin-Positive Localized Prostate Cancer (Q51606266) (← links)
- INPP4B is highly expressed in prostate intermediate cells and its loss of expression in prostate carcinoma predicts for recurrence and poor long term survival. (Q54317525) (← links)
- Proteomic approaches in biomarker discovery: new perspectives in cancer diagnostics. (Q54962725) (← links)
- Circulating and Adipose Tissue mRNA Levels of Zinc-α2-Glycoprotein, Leptin, High-Molecular-Weight Adiponectin, and Tumor Necrosis Factor-Alpha in Colorectal Cancer Patients With or Without Obesity. (Q55048709) (← links)
- cDNA microarray technique on screening multi-drug resistance-related genes of human non-small cell lung cancer (Q55438202) (← links)
- An Analysis of a Multiple Biomarker Panel to Better Predict Prostate Cancer Metastasis After Radical Prostatectomy (Q57027477) (← links)
- AZGP1 mRNA levels in normal human lung tissue correlate with lung cancer disease status (Q57763131) (← links)
- Zinc-α2-glycoprotein as an inhibitor of amine oxidase copper-containing 3 (Q92116745) (← links)
- A Long Intergenic Non-coding RNA, LINC01426, Promotes Cancer Progression via AZGP1 and Predicts Poor Prognosis in Patients with LUAD (Q99584171) (← links)